Table 3:

Univariate analysis of parameters effects on overall survival.

Parameter	Surviving	Dead	P-value
Age (y)	73.8±9.6	73.8±6.5	0.994
Female gender	n=7 (63.3%)	n=4 (36.4%)	0.670
BMI (kg/m2)	29.9±13.7	30.5±6.7	0.903
Smoking history (PY)	47.5±39.2	52.4±41.3	0.785
Tumor location			0.083
RUL	n=4 (19.0%)	n=3 (14.3%)
RML	n=0 (0%)	n=0 (0%)
RLL	n=2 (9.5%)	n=3 (14.3%)
LUL	n=3 (14.3%)	n=3 (14.3%)
LLL	n=3 (14.3%)	n=0 (0%)
Tumor pathology			0.115
PAC	n=6 (28.6%)	n=1 (4.8%)
PSCC	n=3 (14.3%)	n=3 (14.3%)
CG	n=0 (0%)	n=1 (4.8%)
NET	n=1 (4.8%)	n=0 (0%)
NSC-US	n=1 (4.8%)	n=1 (4.8%)
Tumor longest dimen. (mm)	17.0±3.4	18.0±7.5	0.716
Tumor shortest dimen. (mm)	12.7±3.6	13.7±4.6	0.596
Depth from pleura (mm)	21.1±15.3	17.5±15.7	0.620
Pred. FVC %	84.7±15.2	73±21.6	0.093
Pred. FEV1 %	57.1±19.9	47.3±13.7	0.132
FEV1/FVC ratio	53.8±19.3	50.9±14.7	0.726
Comorbidities			0.921
Diabetes	n=1 (4.8%)	n=3 (14.3%)
CHF	n=0 (0%)	n=1 (4.8%)
HTN	n=7 (33.3%)	n=6 (28.6%)
CKD	n=1 (4.8%)	n=1 (4.8%)
HLD	n=5 (23.8%)	n=7 (33.3%)
A.Fib	n=1 (4.8%)	n=3 (14.3%)
Obesity	n=4 (19.0%)	n=5 (23.8%)
Malnutrition	n=0 (0%)	n=1 (4.8%)
CAD	n=3 (14.3%)	n=2 (9.5%)
OSA	n=2 (9.5%)	n=3 (14.3%)

y: Year, BMI: Body mass index, NSC-US: Non-small cell unspecified, PSCC: Pulmonary squamous cell carcinoma, PAC: Pulmonary adenocarcinoma, NET: Neuroendocrine tumor, CG: Caseating granuloma, pred. FVC%: Predicted forced vital capacity, FEV1%: Forced expiration volume in 1 s, PY: Pack-year, CHF: Congestive heart failure, HTN: Hypertension, CKD: Chronic kidney disease, HLD: Hyperlipidemia, A. Fib: Atrial fibrillation, CAD: Coronary artery disease, OSA: Obstructive sleep apnea